Holen Sie sich die Stockscreener-App
3.17
1.86%
-0.06
Handel nachbörslich:
3.15
-0.02
-0.63%
Schlusskurs vom Vortag:
$3.23
Offen:
$3.25
24-Stunden-Volumen:
140.48K
Relative Volume:
0.49
Marktkapitalisierung:
$122.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.1241
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+0.96%
1M Leistung:
+0.32%
6M Leistung:
-5.65%
1J Leistung:
+64.25%
1-Tages-Spanne:
$3.15
$3.2898
1-Wochen-Bereich:
$3.075
$3.30
52-Wochen-Spanne:
$1.595
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Firmenname
Protara Therapeutics Inc
Sektor
Branche
Telefon
646-844-0337
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Vergleichen Sie TARA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
3.17 | 122.30M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-17 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-07-29 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
Should you hold or exit Protara Therapeutics Inc. nowJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Protara Therapeutics shares rise 3.79% intraday after announcing inducement grants to new employees. - AInvest
Technical signs of recovery in Protara Therapeutics Inc.Weekly Stock Report & Consistent Return Investment Signals - Newser
Published on: 2025-09-03 04:42:20 - Newser
How to escape a deep drawdown in Protara Therapeutics Inc.GDP Growth & Technical Entry and Exit Alerts - Newser
Full technical analysis of Protara Therapeutics Inc. stock2025 Top Decliners & Expert Approved Trade Ideas - Newser
What institutional flow reveals about Protara Therapeutics Inc.Share Buyback & Stock Portfolio Risk Management - Newser
Candlestick signals on Protara Therapeutics Inc. stock today2025 Market Sentiment & Reliable Price Action Trade Plans - Newser
What Fibonacci levels say about Protara Therapeutics Inc. reboundRisk Management & Real-Time Chart Breakout Alerts - Newser
Published on: 2025-09-03 00:07:37 - Newser
Market reaction to Protara Therapeutics Inc.’s recent newsWeekly Trading Summary & Fast Gaining Stock Reports - Newser
Published on: 2025-09-02 22:40:30 - Newser
Can momentum traders help lift Protara Therapeutics Inc.2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Aug Catalysts: What is Protara Therapeutics Inc.’s TAM (Total Addressable Market)July 2025 Decliners & AI Forecast Swing Trade Picks - khodrobank.com
Protara Therapeutics’ Equity Inducement Grants: A Strategic Catalyst for Talent Retention and Long-Term Value Creation - AInvest
Protara Therapeutics shares fall 1.89% after-hours following inducement grants to new employees. - AInvest
Protara Therapeutics, Inc. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Biotech Firm Protara Therapeutics Issues $3.17/Share Stock Options in Key Employee Compensation Plan - Stock Titan
Published on: 2025-09-02 12:19:22 - Newser
Protara Therapeutics Inc.’s volatility index tracking explainedPortfolio Return Report & AI Powered Trade Plan Recommendations - Newser
What data driven models say about Protara Therapeutics Inc.’s futureBond Market & AI Forecasted Entry and Exit Points - Newser
Is Protara Therapeutics Inc. vulnerable to short sellers2025 Trading Volume Trends & Intraday High Probability Setup Alerts - khodrobank.com
What is the earnings history of Protara Therapeutics Inc.2025 Performance Recap & Smart Investment Allocation Tips - khodrobank.com
Published on: 2025-09-02 08:13:43 - khodrobank.com
Is Protara Therapeutics Inc. a top pick in the sectorJuly 2025 Rallies & Expert Approved Momentum Ideas - khodrobank.com
Chartists Watching For Breakout in Protara Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
How to use a screener to detect Protara Therapeutics Inc. breakoutsMarket Activity Recap & Real-Time Volume Analysis - Newser
Using economic indicators to assess Protara Therapeutics Inc. potential2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
How to build a dashboard for Protara Therapeutics Inc. stockJuly 2025 Earnings & Low Risk Entry Point Guides - Newser
Is now a turning point for Protara Therapeutics Inc.Weekly Gains Summary & Long-Term Capital Growth Ideas - Newser
Detecting support and resistance levels for Protara Therapeutics Inc.2025 Top Gainers & Free High Return Stock Watch Alerts - Newser
MACD Signals Flash Warning for Protara Therapeutics Inc. Stock getLinesFromResByArray error: size == 0 - kangso.co.kr
Combining machine learning predictions for Protara Therapeutics Inc.July 2025 Market Mood & Target Return Focused Picks - Newser
How to track smart money flows in Protara Therapeutics Inc.Weekly Trade Recap & Scalable Portfolio Growth Methods - Newser
What’s the recovery path for long term holders of Protara Therapeutics Inc.July 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Using data filters to optimize entry into Protara Therapeutics Inc.Price Action & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-08-30 16:26:05 - Newser
Backtesting results for Protara Therapeutics Inc. trading strategiesEarnings Growth Report & Safe Capital Growth Plans - Newser
Can volume confirm reversal in Protara Therapeutics Inc.July 2025 Volume & Expert Approved Momentum Ideas - Newser
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Protara Therapeutics Inc-Aktie (TARA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zummo Jacqueline | Chf Scientific Operations Off |
Mar 26 '25 |
Sale |
4.53 |
21,224 |
96,145 |
98,861 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):